Clinigen's Peter George joins Ergomed board
This article was originally published in Scrip
Guilford, UK-based drug development services company Ergomed has named Peter George to its board as a non-executive director – effective from 21 May 2014. Mr George is currently CEO of global speciality pharma Clinigen. As well as providing clinical development services, Ergomed is building a portfolio of co-development partnerships with pharma and biotech companies which share the risks of drug development.